MEILLEUREHEALTH (02327) Schedules 27 Mar 2026 Board Meeting to Approve FY2025 Results and Dividend Proposal

Bulletin Express
03/12

Meilleure Health International Industry Group Limited (stock code: 02327) has announced that its board of directors will convene on 27 March 2026.

The meeting’s agenda includes: 1. Reviewing and approving the consolidated financial results for the financial year ended 31 December 2025. 2. Considering a recommendation on the payment of a final dividend, if any.

Key timeline: • Board-meeting notice issued: 12 March 2026 • Results period under review: FY2025 (year ended 31 December 2025) • Scheduled board meeting: 27 March 2026

Board composition as at the announcement date: • Executive Directors: Zhou Xuzhou, Dr. Zeng Wentao, Zhou Wen Chuan (also Chief Executive Officer) • Non-executive Director: Dr. Mao Zhenhua • Independent Non-executive Directors: Professor Chau Chi Wai, Wilton; Chen Shi; Wu Peng

The company will release its audited FY2025 results and any dividend decision following the 27 March 2026 board meeting.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10